Cardiovascular Risk Factors - HTN, Lipids and Medications Flashcards
Hypertension
-presentation
-investigation
-diagnosis
Asymptomatic - may initially present as stroke, MI
Severe - headache, nosebleed, chest pain, SOB
GP BP 2x - 140/90+
-if 2 clinic readings are very different, take 3rd and take lower of last 2
=> ABPM/HBPM to confirm - 135/85+
GP BP - 180/120+ => no home check
HTN in U40 => investigate 2ndary cause?
Hypertension management
-Stage 1
ABPM/HBPM - 135/85+
Lifestyle
-diet, exercise => lower BMI, salt
-smoking cessation
-reduce alcohol
If U80 and any of
-target organ damage
-established CVD
-renal disease
-DM
-QRISK 10%+
=> drug treatment
Hypertension management
-Stage 2
-U55, DM
-55+, black
Lifestyle advice + drug
U55, DM
1st line - A, swap if needed
2nd line - A+C
3rd line - A+C+D
55+, black
1st line - C (D if CI)
2nd line - add ARB/ACEi/D
3rd line - A+C+D
4th line =>
-spirololactone if K U4.5
-Ab/Bb if K 4.5+
5th line => specialist advice
Hypertension management
-Stage 3
Refer - same day assessment if
-retinal bleed, papillodema
-life threatening symptoms (new confusion, chest signs, heart failure, AKI)
-pheochromocytoma?
If no same day referral needed => target organ damage check
Yes => drug treatment
No => repeat CBPM in 1wk
How to assess for target organ damage
When would you do this
If Stage 3 HTN => kidney and eye
Urine dip => hematuria
Fundoscopy => HTN retinopathy
ECG
Bloods
-urine albumin:creatinine => proteinuria
-HbA1C
-U&E, eGFR => CKD
BP targets
-U80
-80+
U80
CBPM - U140/90
ABPM/HBPM - U135/85
80+
CBPM - U150/90
ABPM/HBPM - U145/85
ABPM/HBPM if significant white-coat effect
QRISK
-when to use
-results interpretation
CVD risk for primary prevention up to 84 y/o
U10% - lifestyle + comorbidity optimisation
10%+ - +atorvastatin 20mg
Lipid modification therapy
-investigations
-when to suspect familial hypercholesterolemia
-management of high cholesterol 9+if homozygous FH)
-statin, ezetimibe MOA
Investigations
-lipids - current lipid control
-LFT - poor liver function CI
-U&Es, eGFR, HbA1c
Familial hypercholesterolemia - AD
-FHx of CHD
-Total 7.5mmol/L+
-LDL 4.9mmol/L+
-tendon xanthomata
=> refer to lipid clinic
Management
Primary - atorvastatin 20mg
Secondary - atorvastatin 80mg
2nd line - ezetimibe
If homozygous FH
-LDL apheresis
-liver transplant
Statins - inh HMG CoA reductase
Ezetimibe - inh dietary uptake
Statin counselling
-what are statins for
-how to take it
-monitoring
-SE
-lifestyle changes
2 types of cholesterol
-good (HDL)
-bad (LDL) => increased risk of heart attacks and strokes
Statins aim to reduce the amount of LDL
Tablet - OD
-time of day depends on statin used
-take missed doses ASAP but no DD
Before - lipids, LFTs
3, 12months - lipids
CI - liver problems, pregnancy
SE
Common - GI upset
Key - generalised muscle pain => GP
Lifestyle changes
-no grapefruit
-ABx interactions
-CV risk optimisation
Anti-hypertensive counselling
-what are anti-HTNs for
-how to take it
-monitoring
-SE for ACEi, ARB, CCB
-lifestyle changes
High BP => increased risk of heart attacks, strokes
Aim to reduce HTN
Tablet
-slowly increase dose until BP controlled
Before - BP, kidneys
12months - kidney
Home BP monitoring
CI - kidney problems, pregnancy
SE
ACEi - dry cough => GP if a bother
-Hypotension => GP
-Angiodema, anaphylaxis => A&E
CCB
-Headache, swollen ankles, constipation
Lifestyle changes
-avoid NSAIDs
-CV risk optimisation
Diuretic counselling
-what are diuretics for
-how to take it
-monitoring
-CI
-SE
-lifestyle changes
Kidneys filter out water, salts, waste from blood
By using diuretics to remove more water and salt => lower BP
Tablet
-early morning => less disruption to sleep
Before - U&E, kidneys
Initial frequent monitoring until stable
CI - kidney problems
SE
Hypotension, dehydration, dizzy => GP
Lifestyle changes
-CV risk optimisation
Bb counselling
-what are Bb for
-how to take it
-monitoring
-CI
-SE
-lifestyle changes
Bb reduce BP by slowing down HR and reducing force of pulse
Tablet
CI
-COPD, asthma, poor peripheral circulation
SE
-cold peripheries, fatigue
SOB, dizzy, chest pain => GP
Lifestyle changes
-CV risk optimisation
Causes of HTN
Primary - lifestyle factors (CV risk)
Secondary - underlying cause
Renal
-renal artery stenosis
-PKD
Endocrine
-pheochromocytoma
-Hyperaldosteronism
-Cushing
Other
-coarctation of aorta
-pre-eclampsia